WO2001074999A3 - Nouveau polypeptide, deshydrogenase/reductase 14 a chaine courte, et polynucleotide codant pour ce polypeptide - Google Patents

Nouveau polypeptide, deshydrogenase/reductase 14 a chaine courte, et polynucleotide codant pour ce polypeptide Download PDF

Info

Publication number
WO2001074999A3
WO2001074999A3 PCT/CN2001/000242 CN0100242W WO0174999A3 WO 2001074999 A3 WO2001074999 A3 WO 2001074999A3 CN 0100242 W CN0100242 W CN 0100242W WO 0174999 A3 WO0174999 A3 WO 0174999A3
Authority
WO
WIPO (PCT)
Prior art keywords
polypeptide
reductase
polynucleotide encoding
short chain
chain dehydrogenase
Prior art date
Application number
PCT/CN2001/000242
Other languages
English (en)
Chinese (zh)
Other versions
WO2001074999A2 (fr
Inventor
Yumin Mao
Yi Xie
Original Assignee
Shanghai Biowindow Gene Dev
Yumin Mao
Yi Xie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Biowindow Gene Dev, Yumin Mao, Yi Xie filed Critical Shanghai Biowindow Gene Dev
Priority to AU46297/01A priority Critical patent/AU4629701A/en
Publication of WO2001074999A2 publication Critical patent/WO2001074999A2/fr
Publication of WO2001074999A3 publication Critical patent/WO2001074999A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/001—Oxidoreductases (1.) acting on the CH-CH group of donors (1.3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne un nouveau polypeptide, une déshydrogénase/réductase 14 à chaîne courte, et un polynucléotide codant pour ce polypeptide ainsi qu'un procédé d'obtention de ce polypeptide par des techniques recombinantes d'ADN. L'invention concerne en outre les applications de ce polypeptide dans le traitement de maladies, notamment des troubles métaboliques liés à la substance et à l'énergie et des troubles du développement et de la croissance. L'invention concerne aussi l'antagoniste agissant contre le polypeptide et son action thérapeutique ainsi que les applications de ce polynucléotide codant pour la déshydrogénase/réductase 14 à chaîne courte.
PCT/CN2001/000242 2000-03-10 2001-02-26 Nouveau polypeptide, deshydrogenase/reductase 14 a chaine courte, et polynucleotide codant pour ce polypeptide WO2001074999A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU46297/01A AU4629701A (en) 2000-03-10 2001-02-26 A novel polypeptide, short-chain dehydrogenase/reductase 14 and the polynucleotide encoding the polypeptide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN00111968A CN1313388A (zh) 2000-03-10 2000-03-10 一种新的多肽——短链脱氢酶/还原酶14和编码这种多肽的多核苷酸

Publications (2)

Publication Number Publication Date
WO2001074999A2 WO2001074999A2 (fr) 2001-10-11
WO2001074999A3 true WO2001074999A3 (fr) 2002-06-06

Family

ID=4581864

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2001/000242 WO2001074999A2 (fr) 2000-03-10 2001-02-26 Nouveau polypeptide, deshydrogenase/reductase 14 a chaine courte, et polynucleotide codant pour ce polypeptide

Country Status (3)

Country Link
CN (1) CN1313388A (fr)
AU (1) AU4629701A (fr)
WO (1) WO2001074999A2 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000004135A2 (fr) * 1998-07-16 2000-01-27 Incyte Pharmaceuticals, Inc. Molecules apparentees a l'alcool-deshydrogenase chaine courte de type humain, scrm-1 et scrm-2
US6057140A (en) * 1998-06-30 2000-05-02 Incyte Pharmaceuticals, Inc. Human scad family molecules

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6057140A (en) * 1998-06-30 2000-05-02 Incyte Pharmaceuticals, Inc. Human scad family molecules
WO2000004135A2 (fr) * 1998-07-16 2000-01-27 Incyte Pharmaceuticals, Inc. Molecules apparentees a l'alcool-deshydrogenase chaine courte de type humain, scrm-1 et scrm-2

Also Published As

Publication number Publication date
CN1313388A (zh) 2001-09-19
AU4629701A (en) 2001-10-15
WO2001074999A2 (fr) 2001-10-11

Similar Documents

Publication Publication Date Title
WO2001074999A3 (fr) Nouveau polypeptide, deshydrogenase/reductase 14 a chaine courte, et polynucleotide codant pour ce polypeptide
WO2004014946A1 (fr) Nouvelle proteine homo avec fonction de suppression du cancer et sa sequence de codage
WO2002008421A1 (fr) Nouveau polypeptide, recepteur humain 21.45 du facteur de la necrose tumorale, et polynucleotide codant ce polypeptide
WO2002000822A3 (fr) Nouveau polypeptide, sous-unite humaine 2 $g(b) 16.5 du facteur d'initiation necessaire a la synthese proteique, et polynucleotide codant ce polypeptide
WO2002010400A1 (fr) Nouveau polypeptide, arnt-guanine transglycosylase 17.82, et polynucleotide codant ce polypeptide
WO2001075054A3 (fr) Nouveau polypeptide, facteur humain de regulation 30 de la transcription de la microglobuline, et polynucleotide codant pour ce polypeptide
WO2002000826A3 (fr) Nouveau polypeptide, proteine humaine de methylation d'adn, et polynucleotide codant ce polypeptide
WO2001081534A3 (fr) Nouveau polypeptide, oxydoreductase 2fe-2s humaine 12, et polynucleotide codant pour ce polypeptide
WO2001096526A3 (fr) Nouveau polypeptide, facteur humain 11.77 d'inhibition tumorale, et polynucleotide codant ce polypeptide
WO2001075036A3 (fr) Nouveau polypeptide, immunophiline humaine 14, et polynucleotide codant pour ce polypeptide
WO2001075062A3 (fr) Nouveau polypeptide, hydrogenase humaine 10, et polynucleotide codant pour ce polypeptide
WO2001075053A3 (fr) Nouveau polypeptide, chaperonine humaine 14, et polynucleotide codant pour ce polypeptide
WO2001075016A3 (fr) Nouveau polypeptide, tyrosinase humaine 16, et polynucleotide codant pour ce polypeptide
WO2002000824A3 (fr) Nouveau polypeptide, proteine humaine 10.56 du gene cancerigene tre, et polynucleotide codant ce polypeptide
WO2001074993A3 (fr) Nouveau polypeptide, proteine humaine a doigt de zinc 17, et polynucleotide codant pour ce polypeptide
WO2001079436A3 (fr) Nouveau polypeptide, facteur humain de transcription de la differentiation cellulaire 10, et polynucleotide codant pour ce polypeptide
WO2001075018A3 (fr) Nouveau polypeptide, facteur humain de regulation de la transcription 31, et polynucleotide codant pour ce polypeptide
WO2001075024A3 (fr) Nouveau polypeptide, facteur humain 13 associe a nf-e2, et polynucleotide codant pour ce polypeptide
WO2001075023A3 (fr) Nouveau polypeptide, phosphatidylinositol-3 (ptdins 3) kinase humaine 9, et polynucleotide codant pour ce polypeptide
WO2001083678A3 (fr) Nouveau polypeptide, uridylate kinase humaine 13, et polynucleotide codant pour ce polypeptide
WO2001075055A3 (fr) Nouveau polypeptide, quinine reductase humaine 9, et polynucleotide codant pour ce polypeptide
WO2001075025A3 (fr) Nouveau polypeptide, thyroglobuline humaine 9, et polynucleotide codant pour ce polypeptide
WO2001079429A3 (fr) Nouveau polypeptide, facteur humain d'echange guanine nucleotide 10, et polynucleotide codant pour ce polypeptide
WO2001075056A3 (fr) Nouveau polypeptide, clathrine humaine a chaine legere 20, et polynucleotide codant pour ce polypeptide
WO2001075039A3 (fr) Nouveau polypeptide, arn helicase humaine 10, et polynucleotide codant pour ce polypeptide

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP